 | |||||
| lose weight | |||||
| NEWS | |||||
| Adults with obesity lost up to 22.5% of weight at 48 weeks with novel drug - Healio A once-weekly injectable GIP/GLP-1 dual agonist conferred up to 22.5% weight loss at 48 weeks for adults with overweight or obesity, according to ...
| |||||
| Scientists discover weight loss medication users could be majorly lacking in one area The study found that introducing an exercise routine while on your medicated weight loss journey had a number of health benefits. Including improving ...
| |||||
| Food companies are targeting users of weight-loss drugs with 'GLP-1 Friendly' labels Meals and snacks with "GLP-1 Friendly" labels on the packaging are becoming more common as a growing number of Americans try obesity drugs like ...
| |||||
| See more results | Edit this alert | |||||
| You have received this email because you have subscribed to Google Alerts. |
 Receive this alert as RSS feed |
| Send Feedback |
